Bond Gilead Sciences 2.4% ( US375558AR43 ) in USD
| Issuer | Gilead Sciences | ||||||
| Market price | 100.00 % ⇌ | ||||||
| Country | United States
|
||||||
| ISIN code |
US375558AR43 ( in USD )
|
||||||
| Interest rate | 2.4% per year ( payment 2 times a year) | ||||||
| Maturity | 01/12/2014 - Bond has expired | ||||||
|
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 750 000 000 USD | ||||||
| Cusip | 375558AR4 | ||||||
| Standard & Poor's ( S&P ) rating | NR | ||||||
| Moody's rating | NR | ||||||
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558AR43, pays a coupon of 2.4% per year. The coupons are paid 2 times per year and the Bond maturity is 01/12/2014 The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558AR43, was rated NR by Moody's credit rating agency. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558AR43, was rated NR by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||
Français
Italiano
United States